GSK Asks Judge To Rule In Teva IP Case, Citing Opioid Deals
By Andrew Karpan · July 11, 2024, 5:19 PM EDT
A GlaxoSmithKline lawyer has urged a Delaware federal judge to make up his mind about a nearly $400 million patent case against Teva Pharmaceuticals in light of unrelated "opioid-related cases" that the...
To view the full article, register now.